National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI) and National Institutes of Health have reported that Lixte’s novel compound, LB-1.2, enhances the
Winner Medical has signed an agreement with a consumer products company in China, to provide PurCotton rolls. Under the agreement, Winner Medical will provide PurCotton raw materials, which
Alcon has discontinued development of anecortave acetate meant for the reduction of intraocular pressure (IOP) associated with glaucoma. The company recently reviewed interim efficacy and safety data from
Kathleen Sebelius, Secretary of the US Department of Human Health and Services (HHS), has announced that the US will provide 420,000 treatment courses of Tamiflu to the Pan-American
Oncolytics has completed the patient enrolment in the phase II component of a phase I/II UK trial of Reolysin combined with paclitaxel/carboplatin. It is intended for patients with
Johnson & Johnson (J&J) and Elan have signed an agreement whereby J&J (through a newly formed company) will acquire all the assets and rights of Elan related to
Myriad Genetics has completed the spin off of Myriad Pharmaceuticals. Also, the company has received a Private Letter Ruling from the Internal Revenue Service. It states that the
Genentech has announced that the phase-III study of Bravo showed that Lucentis (ranibizumab injection) improved vision in patients with macular edema due to branch retinal vein occlusion. Lucentis
Connectyx has entered into an agreement with Healthy Directions, to promote and sell Connectyx’s MedFlash products through its various distribution channels. Tom Callahan, Senior Vice President of Healthy
Interleukin has executed an agreement to sell the Alan James Group assets of its subsidiary to Pep Products, a subsidiary of Nutraceutical, for approximately $4.6 million. Lewis Bender,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.